Literature DB >> 3623021

Multiple primary malignant tumors.

V S Swaroop, S J Winawer, R C Kurtz, M Lipkin.   

Abstract

Members of colon cancer-prone nonpolyposis families who had multiple primary malignant tumors were analyzed to determine the frequencies, locations, and stages of their cancers, and the duration of their survival. Colon cancers tended to be more proximal, were in a less advanced stage than in the general population, and in a majority of instances were associated with colonic adenomas. The multiple primary malignant tumors were more common in women, and occurred at a younger age than in the general population. Six or more multiple primary malignant tumors occurred in each of 4 patients. All patients survived for more than 10 yr after the diagnosis of the first cancer. Extracolonic cancers were most frequent in the breast and endometrium.

Entities:  

Mesh:

Year:  1987        PMID: 3623021     DOI: 10.1016/0016-5085(87)90440-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

1.  Multiple primary malignant neoplasms in urologic patients.

Authors:  Osman Inci; Esat Kaya; Bulent Alagol; Irfan Huseyin Atakan; Sabahattin Aydin; Hasan Ereselli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

2.  Survival in colorectal carcinoma associated with previous extracolonic cancer.

Authors:  P P Varty; P Delrio; P B Boulos
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

3.  Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.

Authors:  Kefeng Lei; Xujun He; Leibo Yu; Chao Ni; Hailong Chen; Dandan Guan; Kewang Sun; Hai Zou
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

4.  Risk Factors and Genetic Biomarkers of Multiple Primary Cancers in Esophageal Cancer Patients.

Authors:  Pei-Wen Yang; Mei-Chun Lin; Pei-Ming Huang; Cheng-Ping Wang; Tseng-Cheng Chen; Chun-Nan Chen; Mong-Hsun Tsai; Jason Chia-Hsien Cheng; Eric Y Chuang; Min-Shu Hsieh; Pei-Jen Lou; Jang-Ming Lee
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.